Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Case Brabham"'
Autor:
Heather I. Greenwood, Cristian K. Maldonado Rodas, Rita I. Freimanis, Alexa C. Glencer, Phoebe N. Miller, Rita A. Mukhtar, Case Brabham, Christina Yau, Jennifer M. Rosenbluth, Gillian L. Hirst, Michael J. Campbell, Alexander Borowsky, Nola Hylton, Laura J. Esserman, Amrita Basu
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract New approaches are needed to determine which ductal carcinoma in situ (DCIS) is at high risk for progression to invasive ductal carcinoma (IDC). We retrospectively studied DCIS patients who declined surgery (2002–2019), and received endocr
Externí odkaz:
https://doaj.org/article/1470ee587e164affa1e41c9b96a0b37b
Autor:
Mary Kathryn Abel, Heather Greenwood, Tatiana Kelil, Ruby Guo, Case Brabham, Nola Hylton, Jasmine Wong, Michael Alvarado, Cheryl Ewing, Laura J. Esserman, Judy C. Boughey, Rita A. Mukhtar
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Neoadjuvant therapy in breast cancer can downstage axillary lymph nodes and reduce extent of axillary surgery. As such, accurate determination of nodal status after neoadjuvant therapy and before surgery impacts surgical management. There ar
Externí odkaz:
https://doaj.org/article/1b187953753b420cbc254c12bdb82efa
Autor:
Laura J. Esserman, Alexander D. Borowsky, Michael J. Campbell, Gillian L. Hirst, Jennifer M. Rosenbluth, E. Shelley Hwang, Paul Kim, Case Brabham, Rita A. Mukhtar, Amrita Basu, Rita Freimanis, Cristian K. Maldonado Rodas, Heather Greenwood, Phoebe N. Miller, Alexa C. Glencer
Supplementary Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a842b13e6d1220a45db877e148e2ed
https://doi.org/10.1158/2767-9764.22545924
https://doi.org/10.1158/2767-9764.22545924
Autor:
Laura J. Esserman, Alexander D. Borowsky, Michael J. Campbell, Gillian L. Hirst, Jennifer M. Rosenbluth, E. Shelley Hwang, Paul Kim, Case Brabham, Rita A. Mukhtar, Amrita Basu, Rita Freimanis, Cristian K. Maldonado Rodas, Heather Greenwood, Phoebe N. Miller, Alexa C. Glencer
Ductal carcinoma in situ (DCIS) is a biologically heterogenous entity with uncertain risk for invasive ductal carcinoma (IDC) development. Standard treatment is surgical resection often followed by radiation. New approaches are needed to reduce overt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6efa55014bf407ee1113c4500cb2ab2e
https://doi.org/10.1158/2767-9764.c.6551055
https://doi.org/10.1158/2767-9764.c.6551055
Autor:
Alexa C. Glencer, Phoebe N. Miller, Heather Greenwood, Cristian K. Maldonado Rodas, Rita Freimanis, Amrita Basu, Rita A. Mukhtar, Case Brabham, Paul Kim, E. Shelley Hwang, Jennifer M. Rosenbluth, Gillian L. Hirst, Michael J. Campbell, Alexander D. Borowsky, Laura J. Esserman
Publikováno v:
Cancer research communications, vol 2, iss 12
Ductal carcinoma in situ (DCIS) is a biologically heterogenous entity with uncertain risk for invasive ductal carcinoma (IDC) development. Standard treatment is surgical resection often followed by radiation. New approaches are needed to reduce overt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93544969ae54088f07835a07ae9287ce
https://escholarship.org/uc/item/0147j8n0
https://escholarship.org/uc/item/0147j8n0
Autor:
Rita A. Mukhtar, Judy C. Boughey, Michael Alvarado, Case Brabham, Mary Kathryn Abel, Nola M. Hylton, Heather I. Greenwood, Laura J. Esserman, Jasmine Wong, Cheryl Ewing, Ruby Guo, Tatiana Kelil
Publikováno v:
npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
NPJ breast cancer, vol 7, iss 1
NPJ Breast Cancer
NPJ breast cancer, vol 7, iss 1
NPJ Breast Cancer
Neoadjuvant therapy in breast cancer can downstage axillary lymph nodes and reduce extent of axillary surgery. As such, accurate determination of nodal status after neoadjuvant therapy and before surgery impacts surgical management. There are scarce
Autor:
Rick Baehner, April S. Liang, Alexander D. Borowsky, Rita I. Freimanis, Gillian L. Hirst, Shelley Hwang, Gregor Krings, Amrita Basu, Paul Kim, Nola M. Hylton, Heather I. Greenwood, Laura J. Esserman, Rita A. Mukhtar, Case Brabham
Publikováno v:
Cancer Research. 81:PS1-03
Introduction: Standard treatment for ductal carcinoma in situ (DCIS) involves surgical excision with radiation and often endocrine therapy. However, not all DCIS progresses to invasive ductal carcinoma (IDC); thus, surgical intervention may constitut
Autor:
Cheryl Ewing, Jasmine Wong, Rita A. Mukhtar, Case Brabham, Ruby Guo, Michael Alvarado, Laura J. Esserman, Mary Kathryn Abel
Publikováno v:
The breast journalREFERENCES. 27(4)
Autor:
Jasmine Wong, Case Brabham, Kelly Fahrner-Scott, Mary Kathryn Abel, Cheryl Ewing, Rita A. Mukhtar, Michael Alvarado, Laura J. Esserman, Ruby Guo
Publikováno v:
Am J Surg
BACKGROUND: The safety of breast conservation therapy (BCT) has not been demonstrated in large ILC tumors, potentially contributing to the higher mastectomy rates seen in ILC. METHODS: We queried a prospectively maintained database to identify patien
Autor:
Rita I. Freimanis, Amrita Basu, Paul Kim, Rita A. Mukhtar, April S. Liang, Nola M. Hylton, Heather I. Greenwood, Gillian L. Hirst, Laura J. Esserman, Case Brabham
Publikováno v:
Cancer Research. 81:PD5-01
Purpose: Standard treatment for ductal carcinoma in situ (DCIS) involves surgical excision usually with radiation therapy or mastectomy and often endocrine therapy, treatments that are the same as for invasive cancer (IDC). It is clear, however that